Dr. Lisa Bodei, MD, PhD

Dr. Bodei practices at Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center.

Dr. Bodei's NPI, 1174975965, was assigned on July 6, 2016. Dr. Bodei graduated from University of Pisa Faculty of Medicine in 1995. Dr. Bodei holds New York license 283265.

Dr. Bodei's primary practice is Memorial Sloan Kettering Cancer Center, at 1275 York Avenue, New York, NY 10065.

Dr. Bodei's primary practice is Memorial Sloan Kettering Cancer Center in New York, New York, part of Memorial Sloan Kettering Cancer Center. The medical group on file is Memorial Nuclear Medicine Group. Dmand AI also links Dr. Bodei to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bodei practices. Vendor and product names are available with a free account.

Nuclear imaging and therapy is Dr. Bodei's primary specialty in the NPI Registry, under taxonomy code 207UN0902X. Dr. Bodei is board certified in nuclear medicine by the American Board of Nuclear Medicine. Dmand AI has Dr. Bodei's licenses on file in 3 states: New York, New Jersey and Connecticut.

CMS data shows 730 Medicare services from Dr. Bodei across 6 procedure codes in 2024, for 707 Medicare patients. Medicare paid $64,314 for them.

CMS counts 707 Medicare patients who saw Dr. Bodei in 2024. The largest group is 65 to 74, with 307 patients. 75% of them have cancer, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bodei's median patient age at 70, with 38% women.

In 2024, Dr. Bodei wrote 15 Medicare Part D claims.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Bodei for performance year 2024, reported as part of a group. Dr. Bodei accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bodei as offering telehealth.

Dmand AI links 203 papers to Dr. Bodei, published from 2002 to 2025. 2019 was the busiest year, with 18. The most frequent topics are Neuroendocrine Tumors, Radiopharmaceuticals and Octreotide. Dr. Bodei has published most often in Eur J Nucl Med Mol Imaging. Dr. Bodei's most frequent co-authors are Irvin M. Modlin, MD, PhD, Jason E. Lewis, DO and Wolfgang Weber, MD.

Dmand AI links Dr. Bodei to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Neuroendocrine Tumors and Neuroectodermal Tumors. Memorial Sloan Kettering Cancer Center sponsors the most, 2.

CMS Open Payments shows 18 general payments to Dr. Bodei from 7 drug and device companies from 2016 to 2020. Speaker and faculty fees make up the largest share, 36% of the total. Advanced Accelerator Applications paid the most, $2,943.

Dr. Bodei graduated from University of Pisa Faculty of Medicine in 1995.

Dr. Bodei is in network with 4 carriers, including Excellus BlueCross BlueShield, MVP Health Care and CMS Medicare. EPO plans come from the most carriers, 2. Check the plan with the practice before a visit.